Last reviewed · How we verify
NCT06216795
Kidney Volume in Live Donors Kidney Transplant Donors and Recipients
trial in Kidney Transplant; Complications in 1,000 participants. Status unknown.
23 April 2024
Quick facts
| Lead sponsor | Seoul National University Hospital |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 1,000 |
| Start date | 24 May 2022 |
| Primary completion | 23 April 2024 |
| Estimated completion | 31 December 2024 |
| Sites | 1 location across South Korea |
Conditions studied
- Kidney Transplant; Complications — all drugs for Kidney Transplant; Complications →
Sponsor
Seoul National University Hospital
Who can join
18 and older, any sex, with Kidney Transplant; Complications. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The investigators aim to investigate the association between renal volume measured through pre-donation CT auto-segmentation and postoperative renal function of both donors and recipients. After establishing the statistical significance of the association, the investigators intend to create and validate predictive models for renal function at surgery, 1 year, and 3 years postoperatively, incorporating various factors known to contribute to renal function deterioration.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
The role of artificial intelligence measured preoperative kidney volume in predicting kidney function loss in elderly kidney donors: a multicenter cohort study.
Jo EA, Lee J, Moon S, Kim JS, et al · · 2024 · cited 3× · PMID 39116451 · DOI 10.1097/js9.0000000000002030
Verify or expand the search:
- PubMed search for NCT06216795
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Kidney Transplant; Complications
Currently open trials in the same condition.
- NCT07531966 — Vascular Complications After Kidney Transplantation · recruiting
- NCT06958796 — Strategic Help With Immunoglobulin to Enhance Protect Against Late Disease (CMV) · Phase 4 · recruiting
- NCT06798909 — Kidney Transplant Preemptive Therapy or Prophylaxis for CMV Prevention in D+R Recipients · Phase 3 · recruiting
- NCT07033858 — Evaluaion the Short Term Effects of Advograf Plus Rapamiune After Kidney Transplantation · NA · recruiting
- NCT05782543 — Renal Ex Vivo Warm Advanced Resuscitation Through Machine Perfusion · NA · recruiting
Other Seoul National University Hospital trials
Trials by the same sponsor.
- NCT07262944 — EOI Block in Otoplasty With Rib Cartilage Graft · NA · recruiting
- NCT07464210 — Nemtabrutinib, Bortezomib, and Rituximab for WM · Phase 2 · not yet recruiting
- NCT07550803 — Effect of Intraoperative Dexamethasone on Early Postoperative Sleep Quality in Patients Undergoing Nasal Surgery · NA · not yet recruiting
- NCT07522138 — Home-based Self-exercise in Patients With Parkinson's Disease: A Feasibility Study · NA · not yet recruiting
- NCT07476651 — Scout Dose of Resin Microspheres · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06216795 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Seoul National University Hospital
- Last refreshed: 24 January 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06216795.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing